Research News and Research

RSS

Texas hospital officials criticize proposal to limit Obamacare navigators

Texas hospital officials and Democrats complained about proposed state legislation to impose greater training requirements and fees on navigators, while a Florida group gets a grant for outreach to Hispanics.

7 Jan 2014

Maryland's troubled exchange spurs political debate

Democratic and Republican critics of Maryland's dysfunctional exchange urged state officials to consider alternatives to the current online insurance marketplace. The issue has also become campaign fodder for gubernatorial candidates.

7 Jan 2014

Barriers persist to new approaches to medical liability, studies find

Issues of medical liability and tort reform, as well as how they interact with rising health care costs, continue to draw news media interest.

7 Jan 2014

Medicare seeks to tighten drug program rules to fight fraud

Draft regulations issued Monday would overhaul the prescription drug program and could save up to $1.3 billion over five years.

7 Jan 2014

Crowdsourcing fungal metabolites with antitumor activity: an interview with Dr. Robert H. Cichewicz, University of Oklahoma

Fungi have played a large role in the development of many important drugs that are in wide use today. The most well-known of these are the penicillins.

7 Jan 2014

First Edition: January 7, 2014

Today's headlines include a range of reports about state developments related to the health law's online marketplaces as well as details regarding the latest Centers for Medicare & Medicaid Services' figures on health costs.

7 Jan 2014

FDA OOPD grants orphan drug designation to Alitair's Erdosteine for treatment of bronchiectasis

Alitair Pharmaceuticals, Inc., today announced that the Office of Orphan Products Development of the Food and Drug Administration has granted orphan drug designation for its drug candidate, Erdosteine, for the treatment of bronchiectasis. Erdosteine is a mucolytic with antibacterial, anti-inflammatory, and antioxidant properties.

7 Jan 2014

OMICS Group acquires International Journal of Emergency Health

OMICS Group proudly announces the acquisition of International Journal of Emergency Health, a mental health emergency or mental health crisis research based journal. IJEMH, OMICS Group's latest acquisition, is a MEDLINE indexed journal which was initiated in 1999.

7 Jan 2014

Synthetic cannabinoid molecule created for osteoarthritis

Chemical compounds synthesised in the laboratory, similar to those found in cannabis, could be developed as potential drugs to reduce the pain of osteoarthritis.

7 Jan 2014

Elsevier's new generation SciVal provides insights into research landscape

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of the new generation SciVal. SciVal will allow research organizations to analyze the world of research, enabling them to establish, execute and evaluate their research strategies by revealing insights based on Scopus data.

7 Jan 2014

Study identifies strategy to help women climb the academic ladder

More women are choosing science careers, yet women are notoriously underrepresented in senior academic positions—often because they abandon their careers due to pessimism about advancement. New research suggests that putting more women in decision-making roles on the teams that organize symposia could offer a simple, effective step forward.

7 Jan 2014

Oxygen Biotherapeutics announces publication of Phase 3 trial protocol for levosimendan

Oxygen Biotherapeutics, Inc. ("OBI") a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that the protocol of their phase 3 trial for levosimendan has been published on ClinicalTrials.gov, "Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Heart Surgery on Cardiopulmonary Bypass."

7 Jan 2014

ERYTECH proposes to broaden lead product in solid tumors, begins Phase II study in pancreatic cancer

ERYTECH Pharma (Euronext Paris: FR0011471135 - ERYP), a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, provides an update on its development plans to broaden the scope of its lead product ERYASP into the large field of solid tumors and announces the launch of a Phase II study in pancreatic cancer.

7 Jan 2014

Quality of life considerations are key when patients consider bariatric surgery

While weight loss surgery offers one of the best opportunities to improve health and reduce obesity related illnesses, the nearly 100,000 Americans who undergo bariatric surgery each year represent only a small fraction of people who are medically eligible for the procedure. Among those who have surgery, Caucasian Americans are twice as likely as African Americans to have weight loss surgery. On the surface, the data appear to signal racial disparity, but when researchers at Beth Israel Deaconess Medical Center dug deeper to ask why this variation exists, the answer was more complicated.

7 Jan 2014

SPSP 2014 to feature symposia on parenting and happiness, social impacts on health

The Society for Personality and Social Psychology annual conference in Austin, TX, from Feb. 13-15, will feature 80 symposia and more than 2,000 posters on new research in a range of topics - the link between parenting and happiness, social impacts on health, the environment's effects on creativity, factors in the academic gender gap, and more. Join 3,500 behavioral scientists in sunny Austin!

7 Jan 2014

Food labeling, product placement intervention can promote healthy choices

The use of color-coded "traffic light" food labels and changes in the way popular items are displayed appear to have produced a long-term increase in the choice of more healthful food items among customers in a large hospital cafeteria. A Massachusetts General Hospital team reports in the American Journal of Preventive Medicine that the previously reported changes in the proportions of more and less healthy foods purchased in the months after their program began have persisted up to two years after the labeling intervention was introduced.

7 Jan 2014

Horizon, AstraZeneca partner to explore oncology-relevant genotypes to identify novel drug targets

Horizon Discovery and AstraZeneca have entered into a research, collaboration and license agreement to explore a range of oncology-relevant genotypes with the aim of identifying and validating a number of novel drug targets. This deal is the second collaboration between AstraZeneca and Horizon, and follows the announcement in April 2013 of an oncology discovery program to explore Horizon's first-in-class kinase target program, HD-001.

7 Jan 2014

Memorial Sloan-Kettering Cancer Center receives $90M in new financial support from Ludwig

Memorial Sloan-Kettering Cancer Center, along with five other elite academic institutions, will share an unprecedented total of $540 million in new financial support from Ludwig Cancer Research, on behalf of its founder Daniel K. Ludwig. Announced today, the gift is among the largest publicly recorded gifts to cancer research made by a private organization, bringing the total funding to date for Ludwig Centers and endowed professorships at the six institutions to $900 million.

7 Jan 2014

Loyola's Surgery Department ranked 18th in NIH medical school funding in 2013

The Surgery Department of Loyola University Chicago Stritch School of Medicine ranked 18th in the nation in National Institutes of Health medical school funding in 2013, according to the Blue Ridge Institute for Medical Research.

7 Jan 2014

Rice University, MD Anderson analyze complications on costs of complex cancer surgery

Although complications from surgical care for cancer patients may seem infrequent, the costs associated with such outcomes are extremely high, according to researchers from Rice University's Baker Institute for Public Policy and the University of Texas MD Anderson Cancer Center.

7 Jan 2014

Research News and Research

Texas hospital officials criticize proposal to limit Obamacare navigators

Maryland's troubled exchange spurs political debate

Barriers persist to new approaches to medical liability, studies find

Medicare seeks to tighten drug program rules to fight fraud

Crowdsourcing fungal metabolites with antitumor activity: an interview with Dr. Robert H. Cichewicz, University of Oklahoma

First Edition: January 7, 2014

FDA OOPD grants orphan drug designation to Alitair's Erdosteine for treatment of bronchiectasis

OMICS Group acquires International Journal of Emergency Health

Synthetic cannabinoid molecule created for osteoarthritis

Elsevier's new generation SciVal provides insights into research landscape

Study identifies strategy to help women climb the academic ladder

Oxygen Biotherapeutics announces publication of Phase 3 trial protocol for levosimendan

ERYTECH proposes to broaden lead product in solid tumors, begins Phase II study in pancreatic cancer

Quality of life considerations are key when patients consider bariatric surgery

SPSP 2014 to feature symposia on parenting and happiness, social impacts on health

Food labeling, product placement intervention can promote healthy choices

Horizon, AstraZeneca partner to explore oncology-relevant genotypes to identify novel drug targets

Memorial Sloan-Kettering Cancer Center receives $90M in new financial support from Ludwig

Loyola's Surgery Department ranked 18th in NIH medical school funding in 2013

Rice University, MD Anderson analyze complications on costs of complex cancer surgery

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery